About Dune Medical Devices
Dune Medical Devices was founded in 2002 to realize the medical potential of its proprietary tissue characterization technology. Offering surgeons and radiologists the real-time ability to identify cancerous tissues and react immediately, this technology holds the promise for a broad range of surgical and diagnostic applications. On April 2, 2020, Dune Medical Devices was acquired by Dilon Technologies® Inc. Terms of the transaction were not disclosed.
Missing: Dune Medical Devices's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Dune Medical Devices's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Dune Medical Devices
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Dune Medical Devices is included in 4 Expert Collections, including Medical Devices.
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.
Health Monitoring & Diagnostics
Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance
Dune Medical Devices Patents
Dune Medical Devices has filed 28 patents.
Medical imaging, Graphical user interfaces, Medical equipment, Medical physics, Electromagnetic radiation
Medical imaging, Graphical user interfaces, Medical equipment, Medical physics, Electromagnetic radiation
Latest Dune Medical Devices News
Nov 6, 2020
Smart Biopsy Devices Market 2020 Analysis – Dune Medical Devices., innoMedicus Ltd., Intuitive Surgical Smart Biopsy Devices Market By Application (Breast Cancer, Skin Cancer, Liver Cancer, Prostate Cancer, Others), Country (U.S., Canada, Mexico, Brazil, Argentina, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa), Market Trends and Forecast to 2027 Global Smart Biopsy Devices Market report covers strategic profiling of key players in the market, comprehensively analyzing their core competencies, and their strategies such as new product launches, expansions, agreements, joint ventures, partnerships, and acquisitions which are applicable for the businesses with which they can take better steps to improve their strategies to sell goods and services. Market research presents actionable market insights which help create sustainable and money-spinning business strategies. An absolute way to forecast what future holds is to comprehend the trend today. Thus, with this Smart Biopsy Devices Market report, more important aspects of the Medical Devices industry can be focused. Smart Biopsy Devices Market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 3.94 billion by 2027 growing at a CAGR of 5.62% in the above-mentioned forecast period. Increasing demand for minimally invasive procedures and rising cases of cancer worldwide are the factors which are affecting the growth of this market. Access Sample Copy of Research Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-smart-biopsy-devices-market The major players covered in the smart biopsy devices market report are Dune Medical Devices., innoMedicus Ltd., Intuitive Surgical, Canon Medical Systems, USA., Boston Scientific Corporation., BD, Cytogen, among other players domestic and global. Market Share data is available for Global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately. Global Smart Biopsy Devices Market By Application (Breast Cancer, Skin Cancer, Liver Cancer, Prostate Cancer, Others), Country (U.S., Canada, Mexico, Brazil, Argentina, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa), Market Trends and Forecast to 2027 Market Analysis and Insights: Global Smart Biopsy Devices Market Biopsy is a medical test which is mainly used to detect cancers. Different imaging techniques are used so that one can easily identify the area of concern. Smart biopsy helps in the diagnosis of cancer and helps to differentiate healthy cells from tumour cells. Technological advancement in the biopsy procedures and increasing demand for minimally invasive breast biopsy procedures will drive the market growth. Rising adoption of smart biopsy devices for breast cancer and skin cancer as they have the ability to decrease the chances of complications, this factor will enhance the demand of the devices in the market. Unhealthy lifestyle of the people, and increasing cases of cervical cancer among women population is also anticipated to create new opportunities for this market in the forecast period of 2020-2027. This smart biopsy devices market report provides details of market share, new developments, product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief our team will help you create a revenue impact solution to achieve your desired goal. Smart Biopsy Devices Market Scope and Market Size Smart biopsy devices market is segmented of the basis of application. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications. Based on application, the smart biopsy devices market is segmented into breast cancer, skin cancer, liver cancer, prostate cancer, and others. Table of Contents Smart Biopsy Devices Market Country Level Analysis Smart biopsy devices market is analysed and market size insights and trends are provided by application as referenced above. The countries covered in the smart biopsy devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific in the Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa as a part of Middle East and Africa, Brazil, Argentina and Rest of South America as part of South America. North America dominates the smart biopsy devices market due to the high prevalence of cancer patients, while Asia-Pacific is expected to grow at the highest growth rate in the forecast period 2020 to 2027 due to the increasing healthcare spending, and various government initiatives. The country section of the smart biopsy devices report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data. Healthcare Infrastructure growth Installed base and New Technology Penetration Smart biopsy devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for smart biopsy devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the smart biopsy devices market. The data is available for historic period 2010 to 2018. Competitive Landscape and Smart Biopsy Devices Market Share Analysis Smart biopsy devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to smart biopsy devices market. In March 2019, Dune Medical Devices announced that they have completed the first in-man cases for Smart Biopsy. It is an endovascular biopsy device for soft tissue that optimizes the spectroscopy technology for radiofrequency (RF)to classify the tissue in real time. This will help the company to provide multi- cancer, real time, and treatment application. Customization Available: Global Smart Biopsy Devices Market Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report. About Data Bridge Market Research An absolute way to forecast what future holds is to comprehend the trend today! Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. Contact:
Dune Medical Devices Frequently Asked Questions (FAQ)
When was Dune Medical Devices founded?
Dune Medical Devices was founded in 2002.
Where is Dune Medical Devices's headquarters?
Dune Medical Devices's headquarters is located at 43 Leopard Road, Paoli.
What is Dune Medical Devices's latest funding round?
Dune Medical Devices's latest funding round is Acquired.
How much did Dune Medical Devices raise?
Dune Medical Devices raised a total of $46M.
Who are the investors of Dune Medical Devices?
Investors of Dune Medical Devices include Dilon Technologies, The Kraft Group, Evidity Health Capital, ATON Partners, Horizon 2020 and 6 more.
Who are Dune Medical Devices's competitors?
Competitors of Dune Medical Devices include BioProtect, OrthAlign, HydroCision, USGI Medical, Censis Technologies, On-X Life Technologies, nContact Surgical, Cambridge Endoscopic Devices, NeoMend, Cameron Health and 13 more.
Compare Dune Medical Devices to Competitors
MST - Medical Smart Tools was founded in 2004 with the mission to develop image guided surgery technology solutions. The Company aims to improve laparoscopic and other minimally invasive surgical procedures and medical staff effectiveness, thus increasing hospital efficiencies, reducing surgical costs, and improving patient outcomes. MST is working within NGT, a private technological incubator in Nazareth, Israel. MST presents the market with a smart disposable Robotic Arm camera holder for laparoscopy, based on advanced image technology. The system is comprised of a computer-controlled mechanism for mechanical camera motivation, intuitive interface between the surgeon and the mechanical system. The company's R&D efforts are spearheaded by a core group of engineers with expertise in image processing, dynamics of mechanisms, multi-link systems and biomechanics. The Company is backed by strong and experienced management and professional medical advisors.
NeuroSonix is an Israeli medical device company targeting the market of cerebral embolic protection during cardiac surgical and other minimally invasive procedures. NeuroSonix has conceived, developed and patented a technology and medical devices for the prevention of acute cerebral embolism during open-heart cardiac surgery as well as other invasive and minimally-invasive procedures. The company's technology, which is based on ultrasound, aims to enable a non-invasive deflection of embolic material flowing inside the body, away from the cerebral arteries. This new ultrasonic modality aims to reduce the embolic load on the patient's brain. The first product developed by the company is the EmBlocker"ž, intended to provide protection from acute cerebral embolism during cardiac surgical procedures. The Protection Collar, the company's second product, is intended for embolic protection during minimally-invasive procedures and Cath-lab practice.
Advanced Surgical Concepts develops surgical instruments for use in endoscopy and in minimally invasive surgery
Magnetecs designs and manufactures a robotic Catheter Guidance Control and Imaging (CGCI) system for minimally invasive medical procedures. The system's electromagnetic array consists of eight electromagnets in a unique configuration for intelligent guidance of a magnetically-tipped catheter, enabling a physician to precisely and consistently control surgical tools in highly dynamic or previously inaccessible environments while enhancing both the physician's dexterity and the patient's safety.
Axis Surgical Technologies, Inc. aims to develop, manufacture, and market devices that improve quality and efficiency in spinal surgery, especially for minimally invasive surgical techniques. Based in Mountain View, California, Axis offers an integration of visualization and articulation capabilities and provides spinal surgery equipment. Axis' FDA Grant In March 2010, Axis announced that it received 510(k) clearance from the Food and Drug Administration to market its C-MOR„ Visualization Device to use in diagnostic and operative arthroscopic and endoscopic procedures. This portable tool provides visualization and illumination of an interior cavity through either a natural or surgical opening. The ergonomic lightweight device also offers practitioners the convenience of endoscopic visualization and efficient one-handed operating ability; this device can be employed in hospital outpatient departments, ambulatory surgery centers, and office surgery suites.
TissueLink Medical is a developer and distributor of medical devices that for surgical procedures. The company's technology aims to eliminate the need for multiple technologies with the potential to reduce operating room and patient recovery time by enabling precise coagulation and cutting, with no excess damage to tissue. These devices will be used in general and thoracic surgical procedures.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.